David Öling

David Öling is a Director of Molecular Biology and Recombinant Protein Production at AstraZeneca, bringing over eight years of experience in both academic research and the pharmaceutical industry. With a Ph.D. in Microbiology from the University of Gothenburg, David has led the implementation of an end-to-end automated DNA assembly pipeline and has developed various molecular tools for therapeutic applications. Throughout their career, David has focused on collaborative innovation in cross-functional environments, contributing to high-impact publications and successful industry partnerships. They are motivated by improving lives through the delivery of medicines and continue to thrive in challenging research and project management roles.